{
    "clinical_study": {
        "@rank": "164765", 
        "acronym": "RASUNOA", 
        "arm_group": {
            "arm_group_label": "NOAC", 
            "description": "Patients receiving NOAC and suffering from ischemic stroke or intracranial bleeding."
        }, 
        "brief_summary": {
            "textblock": "The registry of acute stroke under new oral anticoagulants (RASUNOA) is a German\n      multicenter, prospective, observational registry performed at about 50 study centers\n      covering about 50.000 acute ischemic strokes and 6000 acute intracranial hemorrhages per\n      year. Study enrollment will be consecutive. The RASUNOA registry study center is the\n      University Medical Center of the Principal Investigator (Heidelberg, Germany). The registry\n      will focus on treatment decisions and concepts in patients being under treatment with a new\n      oral anticoagulant and suffering from acute ischemic or hemorrhagic stroke."
        }, 
        "brief_title": "Registry of Acute Stroke Under New Oral Anticoagulants -Pilot (RASUNOA-Pilot)", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Ischemic Stroke", 
            "Intracranial Hemorrhage"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Ischemia", 
                "Stroke", 
                "Cerebral Infarction", 
                "Intracranial Hemorrhages"
            ]
        }, 
        "detailed_description": {
            "textblock": "The main purpose of the study is to collect information from a large, prospectively\n      enrolling multicentre stroke database regarding the optimal management of ischemic and\n      hemorrhagic stroke during anticoagulation with nOAC. Specifically, we aim to obtain critical\n      information regarding the epidemiology, natural history, laboratory and neuroradiological\n      aspects, clinical consequences, and the effects of treatment (i.e.\n      thrombolysis/interventional recanalisation in ischemic stroke and hemostatic therapy in ICH,\n      respectively) in stroke during nOAC. The Registry is not limited to a specific new OAC but\n      intends to examine stroke during use of any of the approved nOAC. The study is not designed\n      to perform comparisons among the different nOAC."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age >= 18 years\n\n          -  informed consent\n\n          -  acute stroke or intracranial bleeding\n\n          -  therapy with a new oral anticoagulant (Dabigatran\u00ae, Rivaroxaban\u00ae, Apixaban\u00ae,\n             Edoxaban\u00ae)\n\n        Exclusion Criteria:\n\n          -  missing informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients suffering from acute ischemic stroke or intracranial hemorrhage while being anti\n        coagulated. Only patients taking new oral anticoagulants will be included."
            }
        }, 
        "enrollment": {
            "#text": "2000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01850797", 
            "org_study_id": "S-556/2011"
        }, 
        "intervention_browse": {
            "mesh_term": "Anticoagulants"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "oral anticoagulants", 
            "ischemic stroke", 
            "blood thinner", 
            "intracranial hemorrhage"
        ], 
        "lastchanged_date": "May 7, 2013", 
        "link": {
            "description": "RASUNOA - Center Homepage", 
            "url": "http://www.klinikum.uni-heidelberg.de/Schlaganfall-Studien.707.0.html"
        }, 
        "location": {
            "contact": {
                "email": "perdita.beck@med.uni-heidelberg.de", 
                "last_name": "Perdita Beck, SN", 
                "phone": "0049 6221 56", 
                "phone_ext": "38121"
            }, 
            "facility": {
                "address": {
                    "city": "Heidelberg", 
                    "country": "Germany", 
                    "zip": "69120"
                }, 
                "name": "University Hospital Heidelberg"
            }, 
            "investigator": [
                {
                    "last_name": "Jan C Purrucker, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Timolaos Rizos, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "roland.veltkamp@med.uni-heidelberg.de", 
            "last_name": "Roland Veltkamp, Prof.", 
            "phone": "0049 6221 56", 
            "phone_ext": "7504"
        }, 
        "overall_contact_backup": {
            "email": "jan.purrucker@med.uni-heidelberg.de", 
            "last_name": "Jan C Purrucker, MD", 
            "phone": "0049 6221 56", 
            "phone_ext": "37718"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Heidelberg", 
            "last_name": "Roland Veltkamp, Prof.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: ethics committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Rate of hematoma enlargement in patients with ICH between initial imaging and follow-up imaging (CT)", 
                "measure": "Rate of hematoma expansion (ICH)", 
                "safety_issue": "No", 
                "time_frame": "48h after ICH"
            }, 
            {
                "description": "In patients with ischemic stroke while under treatment with any of the new OAC who receive thrombolysis we will measure any hemorrhagic transformation on routine follow-up CT imaging (usually within 24h after thrombolysis)", 
                "measure": "Symptomatic intracerebral haemorrhage after thrombolysis", 
                "safety_issue": "Yes", 
                "time_frame": "24 h"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01850797"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital Heidelberg", 
            "investigator_full_name": "Prof. Roland Veltkamp", 
            "investigator_title": "Senior Physician, Department of Neurology, University Hospital Heidelberg", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University Hospital Heidelberg", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital Heidelberg", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2013"
    }
}